Antibody protection: Passive immunization of neonates against oral AIDS virus challenge

Vaccine

Volumn 21, Issue 24, 2003, Pages 3370-3373

  Ruprecht, Ruth M ^a   Ferrantelli, Flavia ^a   Kitabwalla, Moiz ^a   Xu, Weidong ^a   McClure, Harold M ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

HIV transmission through breastfeeding; Neutralizing monoclonal antibodies; Passive immunization and correlates of immune protection

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2F5; MONOCLONAL ANTIBODY 2G12; MONOCLONAL ANTIBODY 4E10; MONOCLONAL ANTIBODY B12; MONOCLONAL ANTIBODY F105; MONOCLONAL ANTIBODY IGG1B12; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY ISOLATION; BREAST FEEDING; BREAST MILK; CHIMERA; CONFERENCE PAPER; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; INFECTION PREVENTION; MACACA; NEWBORN; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS STRAIN; VIRUS TRANSMISSION;

EID: 0037708018     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00335-9     Document Type: Conference Paper

References (15)

1. Beasley R.P., Hwang L.Y., Lee G.C., Lan C.C., Roan C.H., Huang F.Y.et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet. 2:1983;1099-1102.
2. Koup R.A., Safrit J.T., Cao Y.et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:1994;4650-4655.
3. Ferrantelli F., Ruprecht R.M. Neutralizing monoclonal antibodies against HIV - back in the major leagues? Curr. Opin. Immunol. 14:2002;495-502.
4. Baba T.W., Liska V., Hofmann-Lehmann R.et al. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat. Med. 6:2000;200-206.
5. Hofmann-Lehmann R., Vlasak J., Chenine A.-L., Li P.-L., Baba T.W., Montefiori D.C.et al. Molecular evolution of human immunodeficiency virus env in humans and monkeys: similar patterns occur during natural disease progression or rapid virus passage. J. Virol. 76:2002;5278-5284.
6. Hofmann-Lehmann R., Vlasak J., Rasmussen R.A.et al. Postnatal pre- and post-exposure passive immunization strategies: protection of neonatal macaques against oral-simian immunodeficiency virus challenge. J. Med. Primatol. 31:2002;109-119.
7. Reimann K.A., Li J.T., Veazey R.et al. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J. Virol. 70:1996;6922-6928.
8. Hofmann-Lehmann R., Vlasak J., Rasmussen R.A.et al. Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge. J. Virol. 75:2001;7470-7480.
9. Ferrantelli F., Hofmann-Lehmann R., Rasmussen R.A.et al. Post-exposure prophylaxis with human monoclonal antibodies prevented SHIV89.6P infection or disease in neonatal macaques. AIDS. 17:2003;301-309.
10. Xu W., Smith-Franklin B.A., Li P.L.et al. Potent neutralization of primary human immunodeficiency virus clade C isolates with a synergistic combination of human monoclonal antibodies raised against clade B. J. Hum. Virol. 4:2001;55-61.
11. Zwick M.B., Wang M., Poignard P.et al. Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies. J. Virol. 75:2001;12198-12208.
12. Kitabwalla M., Ferrantelli F., Wang T.et al. Primary African HIV clade A and D isolates: effective cross-clade neutralization with a quadruple combination of human monoclonal antibodies raised against clade B. AIDS Res. Hum. Retroviruses. 19:2003;125-131.
13. Amara R.R., Villinger F., Altman J.D.et al. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/VNA vaccine. Science. 292:2001;69-74.
14. Barouch D.H., Santra S., Schmitz J.E.et al. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science. 290:2000;486-492.
15. Barouch D.H., Kunstman J., Kuroda M.J.et al. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature. 415:2002;335-339.